Price
$175.51
Decreased by -28.85%
Dollar volume (20D)
85.44 M
ADR%
3.93
Earnings report date
Feb 21, 2024
Shares float
37.09 M
Shares short
2.13 M [5.74%]
Shares outstanding
38.60 M
Market cap
9.76 B
Beta
0.59
Price/earnings
240.86
20D range
167.76 266.34
50D range
167.76 266.34
200D range
167.76 348.67

Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally.

The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands.

It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names.

In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands.

The company sells its products through direct sales organizations and distributors.

Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Reported date EPSChange YoY EstimateSurprise
Jul 30, 24 0.64
Increased by +48.84%
0.56
Increased by +14.29%
May 7, 24 0.41
Increased by +78.26%
0.38
Increased by +7.89%
Feb 22, 24 0.76
Increased by +375.00%
0.70
Increased by +8.57%
Nov 2, 23 0.67
Increased by +6.60 K%
0.45
Increased by +48.89%
Aug 1, 23 0.43
Increased by +4.20 K%
0.28
Increased by +53.57%
May 2, 23 0.23
Increased by +2.40 K%
0.11
Increased by +109.09%
Feb 23, 23 0.16
Increased by +60.00%
0.15
Increased by +6.67%
Nov 3, 22 0.01
Decreased by -91.67%
0.01
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 270.95 M
Increased by +26.80%
9.21 M
Increased by +505.72%
Increased by +3.40%
Increased by +419.97%
Jun 30, 23 261.50 M
Increased by +25.51%
18.96 M
Increased by +614.24%
Increased by +7.25%
Increased by +509.71%
Mar 31, 23 241.40 M
Increased by +18.39%
8.56 M
Increased by +10.74 K%
Increased by +3.55%
Increased by +9.05 K%
Dec 31, 22 221.22 M
Increased by +8.43%
3.88 M
Increased by +115.74%
Increased by +1.75%
Increased by +114.51%
Sep 30, 22 213.68 M
Increased by +12.39%
-2.27 M
Decreased by -125.66%
Decreased by -1.06%
Decreased by -122.83%
Jun 30, 22 208.34 M
Increased by +13.07%
-3.69 M
Decreased by -139.94%
Decreased by -1.77%
Decreased by -135.32%
Mar 31, 22 203.90 M
Increased by +20.50%
79.00 K
Decreased by -99.33%
Increased by +0.04%
Decreased by -99.45%
Dec 31, 21 204.01 M
Increased by +22.24%
-24.63 M
Decreased by -775.25%
Decreased by -12.07%
Decreased by -652.41%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY